Viewing Study NCT07285434

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-06-14 @ 8:39 AM
Study NCT ID: NCT07285434
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-12-16
First Post: 2025-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer
Sponsor: Biogenea Pharmaceuticals Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC (Non-small Cell Lung Cancer) View
None Squamous Lung Cancer With FGFR1 Amplification View
None Non-Squamous Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Microlyvaq™ View
None Neoantigen vaccine View
None Quantum molecular coupling View
None AI/ML-driven personalization View
None Th1 polyfunctional T-cell response View
None Pembrolizumab combination View
None Circulating tumor DNA (ctDNA) monitoring View